Ktx-1029

N/A

Report date: 2025/03/25 14:25:42
NME

Base Information

Drug NameKtx-1029
Drug Alias NameKtx-1029KTX-1029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase NSD2 inhibitors
TargetsHistone-lysine N-methyltransferase NSD2
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesK36 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesK36 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A